Di(n-butyl) phthalate (DBP), a widely used plasticizer suspected of having estrogenic properties, was investigated for its effects on the prenatal and early neonatal development of the reproductive tract PTegnant CD rats (n = 10) were given DBP at 0, 250, 500, or 750 mg/kg/day (p.o.) throughout pregnancy and lactation until their offspring were at postnatal day 20. Maternal body weights throughout the dosing period were comparable in all groups. At 750 mg/kg/day, the number of live pups per litter at birth was decreased and maternal effects on pregnancy and postimplantation loss are likely to have occurred. Anogenital distance was decreased at birth in the male offspring at 500 and 750 mg/kg/day. The epididymis was absent or underdeveloped in 9, 50, and 71% of adult offspring (100 days old) at 250, 500, and 750 mg/kg/day, respectively, and was associated with testicular atrophy and widespread germ cell loss. Hypospadias occurred in 3, 21, and 43% of males and ectopic or absent testes in 3,6, and 29% of males at 250, 500, and 750 mg/kg/day, respectively. Absence of prostate gland and seminal vesicles as well as small testes and seminal vesicles were noted at 500 and 750 mg/kg/day. Vaginal opening and estrous cyclicity, both estrogen-dependent events, were not affected in the female offspring, although low incidences of reproductive tract malformations were observed at 500 and 750 mg/kg/ day. In the male offspring, DBP produced the same spectrum of effects elicited by the antiandrogen flutamide. Thus, DBP specifically impaired the androgen-dependent development of the male reproductive tract, suggesting that DBP is not estrogenic but antiandrogenic in the rat at these high dose levels. For human risk assessment, determining if this toxicity is metabolite-mediated will be critical, since marked species differences in metabolism exist. O 1998 Society of Taricology.
Increases in disorders of development and function of the male reproductive tract in humans and in wildlife have led to speculation that in utero exposure to environmental contaminants may be deleterious to the development of the reproductive tract by disrupting the endocrine system (Toppari et al, 1996) . Specifically, Sharpe and Skakkebaek (1993) have hypothesized that environmental chemicals that mimic endogenous estrogens can disturb normal Sertoli cell multiplication, which occurs during prenatal, neonatal, and prepubertal life. This can impair the normal development of the male reproductive system since normal Sertoli cell number and function are critical for the development and function of the reproductive system. Numerous chemicals, including specific phthalate esters, are suspected of exerting estrogenic effects since they interact with the estrogen receptor in vitro .
A variety of industrial processes use phthalate esters, including the manufacture of plastics, lubricants, and cosmetics. There is potential exposure of humans to phthalate esters since these compounds have a wide environmental distribution as a result of their manufacture, use, and disposal (Agency for Toxic Substances and Disease Registry, 1990) . The testicular toxicity of phthalate esters has been extensively studied in the rat, and there are several comprehensive reviews on this subject (e.g., Gray and Gangolli, 1986) . Degeneration of the seminiferous epithelium, resulting in testicular atrophy and decreased sperm production, occurs at high dose levels (>1 g/kg, p.o.) of certain phthalate esters, including di(n-butyl)phthalate (DBP). Pubertal rats are more sensitive than sexually mature animals to the testicular toxicity of specific phthalate esters (Teirlynck et al., 1988) . These agents decrease the responsiveness of the Sertoli cell of the testis to FSH stimulation (Lloyd and Foster, 1988) , which is essential for initiation and maintenance of spermatogenesis. The Sertoli cell may be the primary site of toxicity since receptors for FSH are specific to these cells in the testis; in addition, FSH is of much greater importance for pubertal animals than adults since it is essential for the initiation of spermatogenesis.
In the rat, oral administration of the parent phthalate diester leads to its hydrolysis to the monoester and corresponding alcohol. These reactions are catalyzed by pancreatic Upases and by the mucosa and flora of the gastrointestinal tract (Kluwe, 1982) . In the case of DBP, the monoester mono-nbutyl phthalate (MBP) is apparently the active metabolite for induction of reproductive (Gray and Gangolli, 1986 ) and de-velopmental toxicity (Ema et al, 1995) . Administration of di(2-ethylhexyl)phthalate (DEHP) to lactating rats (Dostal et al, 1987) , indicates that lactational transfer of phthalates and their monoester metabolites is likely to occur.
There is some evidence for reproductive toxicity in adults previously exposed in utero or during the neonatal period to certain phthalate esters. Decreased epididymal sperm count at adulthood and a transitory decrease in testicular weight were observed in rats following exposure to a high dose of DEHP either in utero (Tandon et al, 1991) or throughout lactation (Tandon et al, 1990 ). An early transitory decrease in Sertoli cell number and testis weight was induced in rat neonates exposed to high doses of DEHP (1 g/kg and higher) that affected sperm production without loss of fertility (Dostal et al, 1988) . Administration of butylbenzyl phthalate at a low dose level in drinking water (1 mg/L) to rats during pregnancy and lactation caused a small but statistically significant decrease in testicular size and reduction in sperm production in the adult male offspring (Sharpe et al, 1995) .
The only published multigeneration study for a phthalate ester was a reproductive assessment by continuous breeding (RACB) study conducted by the National Toxicology Program (NTP, 1991; Wine et al, 1997) . This report contains the only robust data showing that a phthalate ester caused more marked adverse effects on the reproductive system in the F, offspring than in the F o parental generation. In that study, SpragueDawley rats consumed a diet containing DBP at 0.1, 0.5, or 1.0% (the average dose levels estimated by the authors were 66, 320, and 650 mg/kg/day). Both sexes of the F o parents were administered DBP before cohabitation and throughout a mating period, during which five litters were produced. Only pups from the last F, litter were raised to adulthood, while receiving dietary DBP, for a further mating trial and postmortem examination. In F| males, testicular atrophy and seminiferous tubule degeneration were observed at the mid and high dose levels, and absent or poorly developed epididymis were observed at all dose levels. Underdeveloped penis, prostate, and seminal vesicles, undescended testes, and decreased sperm production were found at the high dose level at which only one litter was produced by the 20 F, breeding pairs. In contrast, viable litters were produced by all the 20 F o breeding pairs at that dose and the reproductive toxicity was comparatively mild in the F o rats and consisted of decreased number of live pups per litter and pup weights. The marked sensitivity of the F, compared with the F o males suggests that altered male reproductive development was due to in utero, neonatal, and/or pubertal exposure of the F, males. These effects are consistent with the hypothesis proposed by Sharpe and Skakkebaek (1993) , suggesting that phthalates may produce changes in reproductive organ development by an endocrine-mediated mechanism.
The purpose of the present study was to determine if limited exposure of female rats to DBP in utero and during the lactation period (the critical period for Sertoli cell differentiation) leads to abnormalities in reproductive development of their male offspring. In addition, this study aimed to determine if the in vitro evidence for the estrogenicity of DBP is supported by in vivo findings by measuring endpoints known to be sensitive to perinatal exposure to estrogenic chemicals (e.g., anogenital distance, vaginal opening, and estrous cyclicity).
MATERIALS AND METHODS
This study was conducted under federal guidelines for the care and use of laboratory animals (National Research Council, 1996) and was approved by the Cm Institutional Animal Care and Use Committee. Pregnant time-mated CD rats (Sprague-Dawley) were obtained from Charles River Laboratories (Raleigh, NQ on gestation day 0 (GD 0; the day sperm was detected in the vaginal smear). After animals were assigned to a treatment group (n = 10 dams per group) by randomization of body weights, they were individually housed in polycarbonate cages with cellulose fiber chips (ALPHA-dri, Shepherd Specialty Papers, Kalamazoo, MI) as bedding. Animals were kept in the AAALAC-accredited animal facility at CUT in a humidity-and temperaturecontrolled, HEPA-filtered, mass air-displacement room. The room was maintained on a 12-h light-dark cycle at approximately 18-26°C with a relative humidity of approximately 30-70%. Rodent feed (NIH-07, Zeigler Brothers, Gardner, PA) and deionized water in water bottles were provided ad libitum.
Pregnant dams were administered DBP (99.8%, Aldrich Chemical Co., Milwaukee, WI) in corn oil by gavage at 250, 500, or 750 mg DBP/kg/day (8) (9) (10) (11) . This range of dose levels encompassed the highest level used in the NTP RACB study (NTP, 1991) (1.0% in the diet or 650 mg/kg/day) to target a dose that caused reproductive tract malformations in the male offspring without maternal toxicity or fetal death. The control group received the vehicle only (1 ml/kg/day). The treatment period extended from GD 3 throughout pregnancy and lactation until the offspring were at postnatal day (PND) 20, with a 2-day interruption at parturition and on the following day (PND 1-2). Dams were examined for clinical signs of toxicity and their body weights recorded daily before dosing. Food consumption of dams was monitored weekly throughout the dosing period. Dams that died or were euthanized intercurrently during pregnancy or lactation were submitted to a gross pathological examination, including the uterine contents (gross external examination and number of live and dead fetuses, resorptions, implantation sites).
Following delivery of the entire litter (PND 1), live pups were counted and examined for clinical signs of toxicity, and mortality was recorded. The length of the perineum from the base of the sex papilla to the proximal end of the anal opening (anogenital distance) was measured with an electronic caliper (0 04-mm accuracy, Ultra-Cal n, Fowler), and all measurements were performed by one investigator. Pups were grouped by sex according to anogenital distance, and weighed. During the lactational period, pups were weighed weekly in groups (by sex and litter) and examined for gross morphological abnormalities. At weaning (PND 21), pups were identified individually by ear tag and housed in groups of three to five animals according to treatment and sex under the conditions described above for the dams. Individual pup body weights were recorded weekly. Dams were killed by CO 2 asphyxiation when their litters were weaned (PND 21) and body and organ weights (ovary, uterus, liver, and kidneys) recorded. The number of implantation sites was determined by staining the uterine lumen (exposed by cutting the uterus longitudinally) with 10% ammonium sulfide (v/v). Rats that were not pregnant in spite of a sperm-positive smear were killed 6 days after the expected date of parturition, and the uterus was examined for implantation sites.
Vaginal opening was monitored daily from PND 29 until each animal acquired the developmental landmark or PND 48, whichever came first. Beginning at the onset of vaginal opening, daily vaginal lavage was conducted for 2 weeks as previously described (Cooper et al., 1993) . Males were examined for preputial separation (separation of the prepuce from the glans penis) from PND 38 until acquisition. During this period, animals were also inspected for scrotal testes and hypospadias. Postmortem examination was conducted on all male and up to three female offspring per litter at sexual Downloaded from https://academic.oup.com/toxsci/article-abstract/43/1/47/1644253 by guest on 20 January 2019 maturity (100-105 days old). Body and organ weights (liver, kidneys, adrenals, testes, seminal vesicles [with coagulating glands and seminal fluid], epididymides, prostate, uterus, ovaries), position of testes, and gross morphology of the internal and external genitalia were noted at necropsy. Histopathology of the testis was conducted on all rats with gross lesions of the reproductive organs and on up to two gross morphologically normal animals selected randomly from each litter, including controls. The right testis (if missing, the left testis) was placed in Bouin's fixative solution. When the tissue had sufficiently hardened (2-4 h later), two small transverse nicks were made in the capsule to allow penetration of the fixative. Approximately 24 h later, the testis was transferred to 70% ethanol, which was changed twice, and stored until paraffin embedding was performed. Three 5-jmi cross sections were made from the cranial, median, and caudal part of the testis and stained with hematoxylin and eosin. Sperm motility was determined in the right cauda epididymis (if missing, sperm analysis was not conducted), as described by Working and Hurtt (1987) .
Statistical analysis. Statistical analyses were conducted using JMP (version 3.1.5, SAS Institute, Cary, NC). Statistical analysis on the data from F, animals was performed using the litter as the statistical unit. Data was tested for normality (Shapiro-Wilk) and homogeneity of variances (Bartlett) and submitted to a one-way analysis of variance. Post hoc comparisons between the control and each treatment group were done using Dunnett's test Results are expressed as means ± SE. Mean organ weights in DBP groups were significantly different from control using Dunnett's test in spite of the heterogeneity of variances for this particular data. Since the number of live pups per litter, survival of pups at birth and weaning were not normally distributed, a x* analysis was performed on the actual counts and survival data presented as proportions ( Table 2 ). The level of significance used was p < 0.05.
RESULTS

Reproductive Performance
There were no indications of clinical signs of toxicity or significant effects on body weight or food consumption in pregnant and lactating dams at any DBP dose level during the study (Table 1) . Three rats in the 750 mg/kg/day group and one at 500 mg/kg/day were not pregnant and had no implantation sites (Table 1) . Since pregnancy is typically achieved in approximately 85-90% of mated females (Manson and Yang, 1994) , this apparent decrease may be due to the random assignment of successfully mated females among treatment groups but could also be due to preimplantation loss since dosing began on GD 3, before implantation (GD 5-6 in the rat). Length of gestation was 21 or 22 days in all animals. However, one moribund pregnant rat in the control and one in the 250 mg/kg/day group failed to deliver and were euthanized on GD 23. In the control dam, there were 10 fully developed fetuses, one of which was dead in the body of the uterus, but the cervix was not dilated. The uterine lumen of the DBPtreated rat contained large amounts of hemorrhagic fluid and 11 fully developed live fetuses. In addition, one dam in the 750 mg/kg/day group died on GD 19 as a result of severe uterine hemorrhage and had 14 fully formed fetuses. These single incidences are insufficient to conclude that DBP treatment affected parturition. Five animals died during the dosing period from tracheal rather than gastric intubation with the gavage solution, two during pregnancy and three during lactation (Table 1) . Uterine weight at weaning was significantly decreased in dams given 500 mg DBP/kg/day compared to that seen in controls (Table 1) . A similar decrease was observed at 750 mg/kg/day but was not statistically significant, probably as a result of the small number of dams remaining at weaning at this dose level.
The only significant adverse effects of gestational exposure to DBP on reproductive performance was a decrease in the size of litters from rats treated with 750 mg/kg/day (Table 2) . Body weight gain during the second half of pregnancy was slightly lower in this group in comparison to control (Table 1) ; however, this effect is consistent with the smaller litters in DBPtreated rats. Evaluation of the number of implantation sites at PND 21 is an estimate of the number of in utero deaths and cannibalized offspring that occurred prior to examination at PND 1, rather than an evaluation of postimplantation loss. Nevertheless, smaller litters without a reduction in the number of implantation sites suggests that DBP caused postimplantation loss at 750 mg/kg/day. The proportion of pups bom alive, their weights, and sex ratio were not significantly affected by DBP treatment (Table 2 ). Daily administration of DBP to dams during lactation did not affect pup weight gain, pup weight at weaning and beyond (Table 2) . However, pup survival to weaning was decreased at 750 mg/kg/day (Table 2) but not from weaning to scheduled termination at PND 100-105.
Male Offspring
The earliest indication of altered development of the reproductive system of the male offspring from DBP-exposed mothers was a dose-dependent reduction in anogenital distance, a developmental landmark for the differentiation of the male external genitalia. At birth, anogenital distance was significantly decreased in male pups at both 500 and 750 mg/kg/day but was unaffected in males at 250 mg/kg/day or in females at any dose level (Fig. 1) . At sexual maturity, the male offspring from mothers treated with DBP also demonstrated a dosedependent increase in the incidence of malformations of the internal and external genitalia (Fig. 2 ). Hypospadias were observed at all dose levels of DBP, with 3, 21, and 43% of rats affected at 250, 500, and 750 mg/kg/day, respectively (Fig. 2) . The typical malformation in adult male offspring consisted of a cleft on the ventral midline near the tip of the penis, with the os of the penis frequently exposed. The size of the penis was also noticeably reduced. Animals with hypospadias frequently had a cleft in the preputial opening. In addition, one animal at 500 mg/kg/day and one at 750 mg/kg/day had a cleft prepuce only. Furthermore, the hypospadias was visible in 2-week-old suckling rats with the urethra opening ventrally at the base of the penis not at the tip (Fig. 3) . Except for animals with hypospadias, the age at onset of preputial separation in grossly normal males was not significantly different across treatment groups (42.5 ± 0.6, 42.6 ± 0.6, 44.4 ±1.1, 45.0 ± 1.5 days for 0, 250, 500, and 750 mg/kg/day, respectively).
Underdeveloped or absent epididymis, frequently bilater- 
0.6 (9) (9) (9) (9) (8) (7) (10) (9) (9) (9) (7) (7) 0.10(7) 4.1 4.4 1.6 (7) (7) (7)* " Sperm-positive female rats were administered com oil or DBP daily by gavage from GD 3 until the offspring were at PND 20, with a 2-day interruption at parturition (PND 1-2).
* One dam that had failed to deliver was moribund and euthanized on GD 23. c One dam died on GD 10 and another on GD 17 due to gavage error, they had 14 and 15 grossly normal fetuses, respectively. One dam died on GD 19 due to severe uterine hemorrhage.
d One dam died on PND 8 due to gavage error, the pups were euthanized. * One dam died on PND 12 and one died on PND 16 due to gavage error. The PND 12 pups were euthanized but PND 16 pups were cross-fostered by randomly distributing them to other litters in the 500 mg/kg/day group.
•^ Values are means ± SE. Number of animals are indicated in parentheses. * Data was not collected from PND 8 to 14. * Significantly different from control, p < 0.05.
ally, was the most common malformation in the male offspring, with 9, 50, and 71% of rats affected at 250, 500, and 750 mg/kg/day, respectively (Fig. 2) . In most cases, epididymal tissue could not be identified in the fat tissue that normally surrounds the epididymis (Fig. 4) . Two animals at 250 mg/kg/ day and six animals at 500 mg/kg/day had a markedly underdeveloped epididymis consisting of an incomplete corpus and/or an incomplete or small caput or cauda. Some animals also had an epididymis that appeared grossly normal but was clearly small compared to control animals. The weight of the grossly normal epididymides was decreased by 14 and 34% at 500 and 750 mg/kg/day, respectively (Fig. 5) .
Generally, small, underdeveloped or absent epididymides were associated with atrophy of the ipsilateral testis, which often had a soft, fluid consistency (Fig. 4) . Mean testis weights were 24 and 33% lower than controls at 500 and 750 mg/kg/ day, respectively (Fig. 5) . Histological examination of the testis revealed moderate to severe degeneration and atrophy of the seminiferous tubules (Fig. 6 ) at all doses of DBP (50-100% of tubules affected). Also, the tubules that did contain germ cells frequently exhibited abnormal or reduced spermatogenesis, characterized by a decrease in the height of the seminferous epithelium with decreased frequency of cells, usually spermatocytes and spermatids. The incidence of animals with DBP-induced seminiferous tubule degeneration increased in a dose-dependent manner; however, the severity of the testicular lesion in affected rats was comparable at all dose levels of DBP (data not shown). Caudal sperm were not detected in all animals with a small or partial right cauda epididymis. In all animals with a morphologically normal epididymis, sperm was present in the cauda epididymis, and its motility was not affected by DBP treatment. Nonscrotal testes upon palpation were observed at all dose levels of DBP (Fig. 2) . Postmortem examination revealed that the testes were ectopic except for one animal at each DBP level that had one testis missing and one scrotal testis. Ectopia was either bilateral or unilateral, but only the right testis was affected in the latter case. Ectopic testes were even smaller than the atrophied scrotal testes in the DBP groups; histologically, widespread germ cell loss was also observed. The ipsilateral epididymis was small, underdeveloped, or absent in these animals.
DBP treatment also affected the development of the accessory reproductive organs. At 500 and 750 mg/kg/day, the seminal vesicles were not developed (Fig. 2) or their weight was decreased by 16 and 32%, respectively (Fig. 5) . The mean weight of the prostate gland (ventral and dorsolateral) was reduced by 27% at 750 mg/kg/day (Fig. 5) . One animal from each of the 500 and 750 mg/kg/day groups had no prostate discernible at postmortem examination.
An increased incidence of dilated renal pelvis, generally affecting the right kidney, was observed in the adult male offspring at all DBP dose levels compared to the control group. However, the occurrence of this alteration did not correlate with those of the reproductive tract. Mean kidney weight was significantly decreased at 750 mg/kg/day compared to that seen in the control group (3.10 ± 0.25 and 3.70 ± 0.10 g, respectively). Body, liver, and adrenal weights of the male offspring of DBP-treated dams were comparable to those of controls.
Female Offspring
In comparison to the outcome seen in the male offspring, DBP treatment had little effect on the development of the reproductive system in the female offspring. Rats without a vaginal opening were seen at 500 (1/30 rats; 1/8 litters) and 750 mg/kg/day (2/9 rats; 1/4 litters). Besides these animals, the age at onset of vaginal opening and first estrus, the length of the estrous cycle, and the frequency of cornified smears in the DBP groups were not significantly different from that seen in controls (Table 3) . At necropsy, the rat in the 500 mg/kg/day group that had no vaginal opening had no patent vagina, no uterus (except for a 65 mm length of horn near the left ovary), and no left kidney. The right uterine horn was half the size of the left in another rat in this dose group. In one animal at 750 mg/kg/ day, the length of the left horn was normal, but only the distal a Males segment of the right horn near the ovary was present. Thus reproductive tract abnormalities, consisting mainly of alterations in the development of the uterus, were induced in the female offspring of mothers treated with 500 and 750 mg DBP/kg/day but at a much lower incidence than in males. Body and organ weights (liver, kidneys, adrenals, ovaries, and uterus in animals with gross morphologically normal horns) in the DBP groups were comparable to those of controls.
DISCUSSION
The major finding of the present study is that daily exposure to high levels of DBP throughout gestation and lactation markedly disturbed the development of the male reproductive system. Small or absent accessory organs (epididymis, seminal vesicles, and prostate), hypospadias, and absent or ectopic testes were observed. In addition, scrotal testes were atrophied and exhibited widespread germ cell loss. The malformations of the reproductive tract due to pre-and perinatal exposure, including testicular atrophy and decreased size of accessory reproductive organs, were not reversible months after cessation of exposure following the attainment of postpubertal age. This outcome showed that prenatal and early neonatal life comprise a sensitive period for induction by DBP of a large spectrum of permanent adverse effects on the reproductive system of the male rat The pattern of malformations observed in this study is similar to that reported in the NTP RACB study at comparable daily dose levels (NTP, 1991) , indicating that protracted intake through the diet and through bolus gavage yield comparable results. This suggests that peak concentrations of DBP do not drive the biological effect at these dose levels. In the current study, however, the offspring were exposed only through the mother during gestation and lactation without the additional direct exposure of the offspring from weaning to sexual maturity included in the NTP study design. Furthermore, dams were exposed during the production of one litter, not continuously during the production of five consecutive litters. Thus similar effects were observed in the present study by using a simpler and shorter experimental design that may prove useful for assessing the toxicity of other structurally related phthalate esters.
Developmental toxicity studies have shown that DBP is teratogenic in rodents at high dose levels, producing external and skeletal malformations in rats (S630 mg/kg/day) and neural tube defects in mice (2 g/kg/day) in the presence of maternal toxicity. DBP is also embryotoxic in the same range of doses in the same studies, causing resorptions and decreased fetal weight in both species (Ema et ai, 1994 (Ema et ai, , 1993 Shiota and Nishimura, 1982; Singh et al, 1972) . No reproductive tract malformations were found in these studies, but the present observations showed such effects at lower doses (without maternal toxicity and fetal loss) than those producing the external and skeletal malformations reported previously in rats. Thus the male reproductive system appears more sensitive than other organ systems to DBP toxicity following prenatal exposure. Since the period of major organogenesis (days 7-15 of gestation in the rat) was the target of previous developmental toxicity assessments, exposure did not span the period when The ratio of affected to total number of rats or litters is indicated above each bar. The control group had 34 rats in nine litters. *Absent or partial epididymis was unilateral or bilateral; small but grossly normal epididymides were not included. §Ectopic and/or absent testis was unilateral or bilateral.
the major development of the reproductive system occurs (days 12-19 of gestation in the rat). In addition, no exposure is occurring from retained DBP following cessation of direct administration, since DBP and MBP are rapidly cleared from the blood and tissues (the half-life of MBP in plasma after a single oral dose of DBP is approximately 5-6 h) (NTP, 1995) . In view of the findings of the present study that administration of DBP throughout gestation (including the period of development of the reproductive system) does, in fact, induce malformations of the male internal and external genitalia, we suggest that the last third of gestation is the sensitive period for the effects of DBP on male sexuaJ differentiation.
The tubular atrophy and extensive loss of the germinal epithelium observed in our study following exposure to 250-750 mg/kg/day DBP during gestation and lactation was also seen after administration of DBP (>2 g/kg/day) and other phthalate esters to pubertal rats (4-5 weeks old) (Gray and Gangolli, 1986) . Decreased Sertoli cell number and loss of spermatocytes was produced in suckling rats (1,2, and 3 weeks old) administered five daily oral doses of DEHP at 1 g/kg/day (Dostal et al, 1988) . We have now shown extensive irreversible seminiferous tubule damage in rats exposed to DBP at 250-750 mg/kg/day through their mother during pre-and early postnatal development. Phthalate esters are thought to exert their primary effect through the Sertoli cell of the testis, and these cells may be even more sensitive during the period of testicular growth, when their number is not yet fixed. Thus exposure to DBP during the period of Sertoli cell division, FIG. 3 . Hypospadias in a 2-week old male offspring from a dam administered 500 mg DBP/kg/day during gestation and lactation. Note the urethra opening vcntrally at the base of the sex papilla.
which spans late gestation until postnatal days 14-16 in the rat (Gondos and Berndtson, 1993) , may result in the most deleterious effects on the testis. In view of the known sensitivity of the neonatal testis to phthalate toxicity, lactational exposure to DBP is likely to have been important for the production of the testicular lesion in the present study. Although all accumulated data clearly show a predilection of the developing testis of neonates and young rats to phthalate toxicity, the sensitivity of the fetal testis is unknown. In the current study, no remnants of the female reproductive tract were found in the male offspring, indicating that DBP did not affect production of Miillerian inhibiting substance by fetal Sertoli cells. Either DBP is not disrupting Sertoli cell function during the prenatal period or it targets a specific function of the fetal testis. An important question that needs addressing is whether narrowing the exposure window to late gestation only also produces testicular toxicity and the structural abnormalities of the reproductive system.
The decrease in litter size at 750 mg DBP/kg/day was to be expected from previous developmental toxicity studies where administration of 600-750 mg DBP/kg/day during organogenesis was deleterious to the survival of the implanted embryo/fetus (Ema et al, 1993; Singh et al, 1972 ). In the current study, exposure from day 3 of gestation did not decrease the number of uterine implantation sites, suggesting that smaller litters at 750 mg/kg/day resulted from resorption. In contrast to this adverse effect of DBP on litter size at the 750 mg/kg/day dose level, the present study showed that DBP was teratogenic at 250 and 500 mg DBP/kg/day, producing reproductive tract malfromations without systemic maternal and neonatal toxicity. There is presently concern that phthalate esters may act as endocrine modulators during development DBP and certain other phthalate esters interact weakly with the estrogen receptor in yeast and mammalian cell systems Meek et al., 1997) . Perinatal exposure to weakly estrogenic chemicals alters sex differentiation in rodents, with more marked effects in females than in males, resulting in precocious vaginal opening, irregular estrous cycles with prolonged or persistent Effect of in utero and lactational exposure to DBP on reproductive organ weights in adult male rats as assessed on PND 100. Values are litter means ± SE for 9, 8, 7, and 4 litters at 0, 250, 500, and 750 mg/kg/day, respectively, except for seminal vesicles and epididymis weight at 750 mg/kg/day (only 3 of the 4 litters had epididymides and seminal vesicles) and epididymis weight at 500 mg/kg/day (n = 6 litters; all the animals in one litter had no epididymides). Epididymis and testes weights were means of right and left organs. *Significantly different from control group (p < 0.05).
estrus, and reduced fertility (Gray et aL, 1989) . However, the present in vivo study has shown that in utero and lactational exposure to 250-750 mg DBP/kg/day had no effect on vaginal opening, estrus cyclicity, or female reproductive organ weight Together, these observations strongly suggest that DBP is not acting as an estrogen in rats even at these high dose levels. Since the differentiation of the female reproductive tract is not under endocrine control, the vaginal and uterine malformations in the offspring of DBP-treated dams are not mediated by an estrogenic mechanism. Phthalate diesters, including DBP, displayed no biological activity in the rat uterotrophic assay (Meek et aL, 1997) , an in vivo screening test for estrogenicity that measures the response of the female reproductive system. Furthermore, MBP, the active metabolite for the testicular toxicity (Cater et aL, 1977) and teratogenicity of DBP (Ema et al., 1995) , does not interact with the estrogen receptor in vitro (T. Zacharewski, pers. commun.). Consequently, the DBP effects on the development of the reproductive system are unlikely to involve binding to the estrogen receptor.
The focus of research in endocrine disruption has primar- ily been on environmental chemicals that interact with the estrogen receptor. However, there is now increasing evidence that some endocrine disrupting chemicals may alter male sexual differentiation through their antiandrogenic activity (Kelce et al., 1997 (Kelce et al., , 1995 . Antiandrogens can disturb the androgen regulation of male sexual differentiation in various ways, for instance by interfering with the production, transport, receptor binding, or elimination of androgens. DBP and other structurally related phthalate esters may act as antiandrogens. In the present study, DBP produced a complete spectrum of effects on androgen-regulated reproductive development. This chemical blocked differentiation of the Wolffian ducts (the anlagen of the epididymis and seminal vesicles) into the epididymis and seminal vesicles, and testicular descent, both of which are testosteronedependent events. DBP also partially demasculinized the TABLE 3 Pubertal Indices in the Female Offspring of Rats Treated with Di(n-butyl) Phthalate during Pregnancy and Lactation external genitalia and disrupted the growth of the prostate, which are regulated by 5a-dihydrotestosterone. Thus DBP exerts its action at the level of both testosterone and 5 adihydrotestosterone-regulated events. The reproductive tract abnormalities, particularly epididymal agenesis, are reminiscent of prenatal exposure to high doses of the antiandrogenic compound flutamide, a competitive inhibitor of androgen binding to the androgen receptor (ImperatoMcGinley et al., 1992) . However, DBP impaired Wolffian duct differentiation into the epididymis to a significantly greater extent than it did the external genitalia and prostate in the present study, whereas the opposite is true for androgen receptor blockade by flutamide (Imperato-McGinley et al., 1992) . This phenotypic difference with flutamide strongly suggests that DBP does not exert its action at the level of the androgen receptor. Furthermore, DBP is unlikely to inhibit 5a-reductase, the enzyme that converts testosterone to its active metabolite, 5a-dihydrotestosterone, since DBP does not specifically block differentiation of the external genitalia and prostate, both 5a-dihydrotestosterone-dependent structures (Imperato-McGinley et al., 1992 , 1985 . All the processes that are affected by DBP are regulated by testosterone either directly (Wolffian duct differentiation) or indirectly through 5a-dihydrotestosterone (external genitalia and prostate differentiation). Thus DBP is likely to exert its action through disruption at some level of the androgen regulation of sexual differentiation during prenatal/early neonatal life.
In summary, this study demonstrated that combined gestational and lactational oral exposure to DBP at doses of 250 mg/kg/day and above markedly impaired the differentiation of the male internal and external genital structures and caused widespread irreversible damage to the seminiferous epithelium of the testis in the rat. Although MBP seems to be the active species for the testicular and developmental toxicity of DBP, it is not clear whether this metabolite also mediates the toxicity described here. This information is critical for addressing human risk assessment since there are marked species differences for the metabolism and toxicity of DBP and other phthalate esters, particularly between rodents and primates (Kluwe, 1982) . Since the major purpose of the current study was not for safety evaluation, future studies will address the detailed doseresponse relationship including lower levels of exposure more relevant to humans. In addition, the role of androgens in DBP-induced alterations in male reproductive tract development will be investigated.
